Cancer Clinical Trials: Lowenthal Group
Our group is active in fostering participation of Tasmanian patients and haematologists/oncologists in national and international trials of new treatments for cancer and blood diseases. We are members of a number of national and international collaborative trials organisations and also are active in carrying out trials on behalf of pharmaceutical companies, under contract.
Parent Theme
Research Projects
Related Funding Bodies
Staff
Members
- Professor Ray Lowenthal (Honorary Member)
Team Members
- Tanya Dargaville (O'Byrne)
- Dr Katherine Marsden (Honorary Fellow)
- Dr Louise Nicholson (Charge Nurse)
Local Collaborators
- Dr Ian Byard
- Sue Davoran
- Elizabeth Hammer
- Dr Rosie Harrup
- Dr Anna Johnston
- Dr Roger Kimber
- Annette Moore
- Lesley Oliver
- Dr Ritam Prasad
- Dr Scott Ragg
- Dr Marketa Skala
- Deirdre Tuck
- Dr Rosemary Young
Related Publications
- Clarke SJ, Yip S, Brown C, van Hazel GA, Ransom DT, Goldstein D, Jeffrey GM, Tebbut NC, Buck M, Lowenthal RM*, Boland A, Gebski V, Zalcberg J, Simes RJ; on behalf of the Australasian Gastro-Intestinal Trials Group. Single-agent irinotecan or FOLFIRI as second-line chemotherapy for advanced colorectal cancer; randomised AGITG phase II study (DaVinci trial) and meta-analysis. European Journal of Cancer 2011; 47: 1826-1836.
* Denotes Menzies Researcher